Project Grant R42HL163783
- The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Lumostech, Inc. under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a smart sleep mask and mobile application to improve sleep for adolescents. The one-year project will apply light flash technology delivered through a sleep mask to advance teenagers' circadian phases without disrupting daytime activities. Cognitive behavioral therapy delivered via mobile...
- This National Science Foundation Project Grant of $255,851 awarded on September 15, 2022 will support the development of a neuromodulation device to promote healthy sleep cycles through the completion of prototype engineering. The awardee, Neurolight Inc. of Suffern, New York, will utilize controlled light and sound stimuli delivered via an externally worn system to transpose normal brain wave patterns associated with desired sleep states into recipients suffering from sleep disorders. This aims...
- This Project Grant, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), supports comprehensive scientific research to investigate the bidirectional relationship between aging and circadian clock disruption. Awarded to Weill Medical College of Cornell University on March 3, 2026, with a total obligation of $109,076.00 and a completion date of September 2, 2029, the project delivers high-throughput molecular and cellular research services using...
- Federal Project Grant Award Summary The University of Pittsburgh received a $790,584 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 4, 2025, with an ultimate completion date of August 31, 2026. This Phase II trial will conduct research to determine the optimal duration of overnight naps for night shift workers—specifically public safety workers and healthcare workers—to restore...
- Federal Grant Award Summary Brigham & Women's Hospital Inc. received a $281,560 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), with performance from September 1, 2025, through August 31, 2027. The grant funds mathematical modeling research on peripheral metabolic circadian rhythms, addressing gaps in current understanding and intervention strategies for circadian rhythm disruption caused by shift...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $155,500 Project Grant to The Washington University, effective August 1, 2025 through July 31, 2027, under the Aging Research program (CFDA 93.866). This grant supports a two-year epidemiological research study investigating the relationship between circadian clock disruption from shift work and osteoarthritis risk in aging populations. The research utilizes the UK Biobank prospective cohort of 500,000...
- Federal Grant Award Summary The National Institute on Aging awarded Massachusetts General Hospital (MGH) $868,901 under the Aging Research program (CFDA 93.866) on March 1, 2026, for the SLEEP-POD2 project (Sleep and Circadian Rhythm Biomarkers of Postoperative Neurocognitive Recovery). This longitudinal research initiative will conduct a comprehensive investigation into the relationship between perioperative sleep disruption, circadian rhythm disturbances, and postoperative delirium (POD) in...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $516,468 to the University of Illinois on March 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on physical activity (PA) timing in relation to glycemic control among night workers versus day workers. The five-year project, concluding February 28, 2031, will recruit 400 non-diabetic participants (200...
- Federal Project Grant Award Summary Award Details: The National Institute on Aging (NIA) awarded Proactive Life Inc. a project grant of $499,963 under the Aging Research program (CFDA 93.866) with an award date of September 20, 2025, and completion date of September 19, 2026. Products and Services: The grant funds development and validation of SleepSpace AI, a fully automated Internet of Things (IoT)-based cognitive behavioral therapy for insomnia (CBTI) system designed to improve sleep...
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $257,400 Project Grant award (R21) from the National Institute of Environmental Health Sciences under the Environmental Health program (CFDA 93.113) effective September 19, 2025, with completion targeted for August 31, 2027. The award funds an epidemiological research study investigating the relationship between environmental exposures—specifically solar jetlag and climate vulnerability—and sleep health disparities in...
REAL-WORLD TRANSLATION OF A DYNAMIC AND PERSONALIZED INTERVENTION FOR SHIFT WORKERS - PROJECT SUMMARY SHIFT WORKERS EXPERIENCE PROFOUND CIRCADIAN DISRUPTION, WHICH CAN HAVE DELETERIOUS LONG TERM EFFECTS ON THEIR HEALTH AND QUALITY OF LIFE. DUE TO THE NECESSITY OF NIGHT SHIFT WORK FOR 24-7 CONTINUOUS OPERATIONS AND SAFETY, IT IS URGENT THAT SOCIETY PRIORITIZE WAYS TO SUPPORT SHIFT WORKER HEALTH. MOOD, FATIGUE, AND PERFORMANCE CAN BE IMPROVED IN SHIFT WORKERS BY SHIFTING THE TIMING OF PRODUCTION OF THE HORMONE MELATONIN OUTSIDE THE HOURS THEY ARE EXPECTED TO WORK. THIS CAN BE ACHIEVED WITH A TARGETED LIGHTING INTERVENTION, AS LIGHT IS THE PRIMARY INPUT TO THE BODY'S CIRCADIAN CLOCK, AND SUPPORTED BY BEHAVIORAL INTERVENTIONS, INCLUDING MEAL AND EXERCISE TIMING. CRAFTING SUCH AN INTERVENTION FOR AN INDIVIDUAL, HOWEVER, REQUIRES KNOWLEDGE OF THE PERSON'S CURRENT BIOLOGICAL TIME, OR CIRCADIAN STATE, WHICH HAS TRADITIONALLY BEEN EXTREMELY CHALLENGING TO ASSESS IN SHIFT WORKERS. THE GOLD STANDARD MEASURE OF CIRCADIAN TIMING IS DIM LIGHT MELATONIN ONSET, OR DLMO. FOR DAY WORKERS, DLMO MOST COMMONLY OCCURS IN A SIX HOUR WINDOW PRIOR TO HABITUAL BEDTIME. FOR FIXED NIGHT SHIFT WORKERS, HOWEVER, DLMO CAN OCCUR ANYTIME OVER THE 24-HOUR DAY. THIS REQUIRES 24 HOURS OF MELATONIN COLLECTION IN ORDER TO ARRIVE AT A SINGLE INDICATOR OF INTERNAL TIME, WHICH IS OFTEN PROHIBITIVELY TIME CONSUMING AND EXPENSIVE. THE SMALL BUSINESS ON THIS PROPOSAL, ARCASCOPE, HAS DEVELOPED NEW TECHNIQUES FOR NONINVASIVELY PREDICTING CIRCADIAN TIMING THROUGH CONSUMER WEARABLE DEVICES (E.G. APPLE WATCH) IN COLLABORATION WITH RESEARCH PARTNER ORGANIZATION HENRY FORD. THESE TECHNIQUES CAN ACCURATELY PREDICT DLMO TIMING IN SHIFT WORKING ADULTS USING CONSUMER WEARABLE DEVICES. THE PIS OF THIS GRANT HAVE ALSO DEVELOPED MATHEMATICAL TECHNIQUES FOR GENERATING LIGHTING RECOMMENDATIONS BASED ON PREDICTED CIRCADIAN TIMING, AIMED AT SHIFTING THE PEAK CIRCADIAN DRIVE TO SLEEP OUTSIDE THE WINDOW OF WORKING HOURS. THESE TECHNIQUES HAVE BEEN EVALUATED IN A PHASE I STTR, THROUGH THE DEPLOYMENT OF AN IOS MOBILE APP, SHIFT, WHICH ACHIEVED LARGE PHASE SHIFTS IN REAL WORLD NIGHT SHIFT WORKERS, DEMONSTRATING THAT IT IS POSSIBLE TO SHIFT THEIR CIRCADIAN RHYTHMS SO THAT THE MELATONIN SECRETION OCCURS OUTSIDE THEIR WORKING HOURS. THE NEXT STEP IN THIS WORK IS TO MOVE BEYOND FEASIBILITY AND TOWARDS EFFECTIVENESS AND IMPLEMENTATION. IN PARTICULAR, IT REMAINS TO BE DEMONSTRATED THAT THE MOBILE APP CAN PRODUCE MEANINGFUL CHANGES IN STAKEHOLDER-CENTERED OUTCOMES IN LARGE, RIGOROUSLY TESTED COHORTS. THESE OUTCOMES INCLUDE NOT ONLY WORKER HEALTH OUTCOMES, SUCH AS DEPRESSION AND SLEEP HEALTH, BUT ALSO QUANTITIES OF CRITICAL IMPORT TO THEIR EMPLOYERS FINANCES, INCLUDING WORKER TURNOVER, SAFETY, AND HEALTH COVERAGE COSTS. IN THIS PHASE II PROJECT, WE PROPOSE TO EVALUATE HOW THE SHIFT APP CAN AFFECT THESE OUTCOMES, DEMONSTRATE NONINFERIORITY OF AN ANDROID VERSION, AND ASSESS KEY FACILITATORS AND BARRIERS TO ENGAGEMENT AND IMPLEMENTATION.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $628.5k | 8/8/25 | ||
| Not listed | $0 | 8/7/24 | ||
| Not listed | $693.4k | 7/5/24 | ||
| Not listed | $693.4k | 7/5/24 |